SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001017062-02-001059
Filing Date
2002-05-22
Accepted
2002-05-22 16:39:41
Documents
6
Period of Report
2002-05-16
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.txt 8-K 7770
3 PRO FORMA RATIO OF EARNINGS dex121.txt EX-12.1 2159
4 CONSENT OF ERNST & YOUNG LLP dex231.txt EX-23.1 3172
5 PRO FORMA BALANCE SHEET dex991.txt EX-99.1 35090
6 AMGEN'S PRO FORMA RATIO OF EARNINGS dex992.txt EX-99.2 1291
7 IMMUNEX'S CONSOLIDATED BALANCE SHEETS dex993.txt EX-99.3 129238
  Complete submission text file 0001017062-02-001059.txt   181046
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 02660049
SIC: 2836 Biological Products, (No Diagnostic Substances)